Noveome Biotherapeutics, Inc. — Form D/A

Noveome Biotherapeutics, Inc. of PITTSBURGH, PA, a company, filed a Form D amendment with the SEC on 2024-08-08. The offering totals $51.3M, of which $36.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Houman HemmatiDirectorBeachwood, OH
Michael KaufmanDirectorBeachwood, OH
Eric KellerDirectorMcLean, VA
Robert LangerDirectorPittsburgh, PA
Craig NemiroffDirectorBeachwood, OH
Ronald PoropatichDirectorPittsburgh, PA
Gretchen KraemerExecutive OfficerPittsburgh, PA
Patrick WelchExecutive OfficerPittsburgh, PA
William GoldenDirectorPittsburgh, PA
William GoldenExecutive OfficerPittsburgh, PA
William GoldenRelated PersonPittsburgh, PA
Robert LangerRelated PersonPittsburgh, PA
Patrick WelchDirectorPittsburgh, PA
Patrick WelchRelated PersonPittsburgh, PA
Patric WelchDirectorPittsburgh, PA
Patric WelchExecutive OfficerPittsburgh, PA
Terence GoldenDirectorPittsburgh, PA
Terence GoldenRelated PersonPittsburgh, PA
Donald WagnerDirectorPittsburgh, PA
Donald WagnerRelated PersonPittsburgh, PA
John McArthurDirectorPittsburgh, PA
John McArthurRelated PersonPittsburgh, PA
A. Clarke AtwellDirectorPITTSBURGH, PA
A. Clarke AtwellExecutive OfficerPITTSBURGH, PA
George SingDirectorPITTSBURGH, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-08-17D$40.2M$20.7M
2020-10-02D$15.0M$870K
2019-04-22D/A$15.0M$15.0M
2018-01-24D$15.0M$2.4M
2016-04-14D/A$2.5M$2.2M
2016-01-13D$2.5M$1.7M
2012-07-12D$571K$571K

More